close icon

BAC Stock on Its Elliott Wave Path to the North

A little over two months ago, on July 2nd, we published an article about Bank of America stock. The price was then hovering near $28.20 a share, following a decline from as high as $33.05 in March. Fortunately, despite the 15% plunge, the Elliott Wave Principle (and the company’s fundamentals, by the way) suggested BAC stock should start recovering very soon. The price chart our analysis was based on is shown below to refresh your memory.
bank of america stock elliott wave analysis
The decline from $33.05 looked like a perfect A-B-C zigzag correction. Wave A was a textbook five-wave impulse, followed by an expanding flat correction in wave B and an ending diagonal in the position of wave C. The trend preceding this three-wave retracement was pointing north, so it made sense to expect the uptrend to resume, once wave 5 of C completes the pullback.

Given the company’s generous share buyback program and strong earnings growth, this was one of those sweet situations, when the bullish idea receives a double confirmation – first from Elliott Wave analysis and then from the underlying business. Two months later, BAC stock bulls look determined to keep climbing the valuation mountain.
BAC stock Elliott Wave forecast update
BAC stock fell to $27.64 on July 6th and then surged sharply to $31.91 by August 8th for a total return of 15.4% in just over a month! Last Friday, the market closed at $30.93, but in our opinion, it is too early to give up on Bank of America. The rally to $31.91 has a five-wave structure, meaning the current weakness is probably just a small a-b-c correction. Wave “c” of 2 might even drag the stock below the $30 mark again, but as long as BAC trades above $27.64, the positive outlook remains intact. A new all-time high by the end of the year cannot be ruled out as a possibility.

Did you like this analysis? You can learn to do it yourself with our Elliott Wave Video Course!

Disclosure: The author has a long position in BAC stock.

Stay informed with our newsletter

Latest Elliott Wave analysis on different topics delivered to you weekly.

Privacy policy
You may also like:

Shopify is One of Many Bubble Stocks Out There

It is becoming pretty clear that a speculative bubble is inflating right now. Money-losing companies with market caps in the tens and even hundreds of billions of dollars have become the norm, not the exception. People, who have been in the market for just a couple of months are bragging online about the phenomenal returns…

Read More »

Undervalued Bristol Myers Stock Can Still Get Cheaper

It’s been almost two years since we shared our bullish stance on Bristol Myers stock. Shares in the pharmaceutical major were changing hands for less than $46 in April, 2019. The company had just announced its planned acquisition of Celgene for about $74 billion and Wall Street apparently didn’t like the risks involved. However, the…

Read More »

DraftKings on the Verge of Another 40% Decline

It’s been almost three and a half months since we examined DraftKings stock in October, 2020. The share price was hovering near $57 after a strong run from $10.60 to over $64 in just several months. The regulatory environment in the U.S. seemed to be warming up and many analysts hurried to issue their BUY…

Read More »

AMN Healthcare Stock to Suffer a 2020-Like Drop

AMN Healthcare Services provides workforce and staffing solutions to healthcare facilities in the U.S. The company is relatively small with a market capitalization of less than $4 billion. However, small companies can make for excellent returns if one happens to identify the winners. And indeed, between late-2011 and early-2020, AMN stock from under $4 to…

Read More »

Zoetis Stock Getting Ahead of Itself, Invites Correction

Based in Parsippany, NJ, Zoetis Inc. is an animal medicine and vaccine developer and manufacturer. The company went public in 2013 and has been enjoying steady growth since. With the stock currently above $160 a share, Zoetis holds a market cap of nearly $80 billion. For a profitable and growing company like Zoetis, a rising…

Read More »

CBOE Stock Looking Good After a Record Year

CBOE Global Markets Inc. is an equities, options and futures exchange operator in the U.S. and Europe. The company traces its roots back to Chicago in 1973, when it practically invented options trading in its present form. CBOE is literally part of the very infrastructure of modern financial markets. So it is not surprising that…

Read More »

Novo Nordisk Bulls Have an Elliott Wave Problem

Novo Nordisk A/S is a Danish pharmaceuticals major with a market cap of over $160 billion. People need their medication even in recessions, so the company’s business wasn’t as affected by the 2020 crisis as most other industries. Novo Nordisk remains a top-notch pharma with consistent profits and revenue and no debt whatsoever. And the…

Read More »

More analyses